Quantitative Monitoring of Neuromuscular Blockade
Your opportunity to improve clinical outcomes
TetraGraph is a quantitative neuromuscular transmission monitor which is easy to use and features gold standard EMG technology for accurate measurements, bringing confidence to your anesthesiology practice.
Through the accurate meaurements, TetraGraph supports your neuromuscular blockade management from start to finish during the surgical procedure and helps you to confirm a train-of-four ratio ≥ 0.9 prior to extubation.
In addition, the monitor has a quick start up-time and does not require calibration. The patient’s arm can be tucked under surgical drape and can thus be used in all types of procedures.
Grounded in science to improve patient safety
It started with a patient who had RNMB.
As a young trainee, Dr. Brull had a patient with residual blockade. He could not stop thinking about what could have been done differently and how this could have been prevented. There was a huge unmet need for an accurate and simple to use neuromuscular monitor.
A R&D project was initiated to develop an EMG-based, portable train-of-four monitoring system. In 2018, the TetraGraph system received CE mark. In November 2019, TetraGraph received FDA 510 clearance.
Since the market introduction of TetraGraph, we have helped thousands of users to prevent the preventable and make anesthesia practice safer.
“We can do better for our patients. Nothing should stop us now when we have the tools we need.“
Sorin J. Brull, MD FCARCSI (Hon) Professor Emeritus of Anesthesiology and Perioperative Medicine, Mayo Clinic
ASA Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade
Based on the type of technology recommended by ASA
ASA’s new guidelines recommend against clinical assessment alone to avoid residual neuromuscular blockade when neuromuscular blocking drugs are administered, and also strongly recommends quantitative monitoring over qualitative assessment to avoid residual neuromuscular blockade.
In addition, the guidelines state a recommendation of confirming a train-of-four ratio greater than or equal to 0.9 before extubation.
TetraGraph is a quantitative neuromuscular monitor, based on state-of-the-art EMG technology, enabling you as a clinican to make confident decisions from start to finish of a procedure.
Your partner in the intensive care unit (ICU)
The TetraGraph is an effective tool to address the daily challenges of paralytic monitoring in the intensive care setting and provides continuous and accurate results.
Make confident titrations with our reliable device, by knowing your patient’s depth of paralysis.
Easy to use. Consistent results. Let the TetraGraph be your trusted partner in paralytic management.
